Erythrocytosis during SGLT2 Inhibitor Therapy: Should We Be Concerned?. Portuguese Kidney Journal, [S. l.], 2026. DOI: 10.71749/pkj.168. Disponível em: https://pkj.spnefro.pt/index.php/journal/article/view/168.. Acesso em: 13 nov. 2026.